Sickle Cell Anemia: A Serious Genetic Disorder with No Advantages

Sickle cell anemia is a severe, lifelong inherited blood disorder caused by a mutation in the HBB gene, producing abnormal hemoglobin S (HbS).

Key Facts:

  • No Health Advantages: Unlike sickle cell trait (one copy), which confers malaria resistance, the disease (two copies) offers no benefit.
  • Pathophysiology: HbS polymerizes under low oxygen, distorting red blood cells into rigid sickle shapes that block microvasculature, causing ischemia, pain, and organ damage.
  • Complications: Vaso-occlusive crises (severe pain), anemia, stroke, acute chest syndrome, infections, organ failure, leg ulcers.
  • Treatment: Hydroxyurea (increases fetal hemoglobin), voxelotor, crizanlizumab, blood transfusions, penicillin prophylaxis, vaccines. Curative: allogeneic stem cell transplant or emerging gene therapies.
  • Life Expectancy: Improved to 50s–60s in high-resource settings with comprehensive care.

Early diagnosis (newborn screening), multidisciplinary care, and patient education are vital for quality of life.

Blood Disorders - Related Articles